10 Pfizer executives
Every one of these Pfizer executives holds a current Pfizer title: the Chairman and Chief Executive Officer, five chief officers for research and development, global supply, information, AI and data, and people experience, three presidents for primary care and the US, hospital and biosimilars, and emerging markets, and the CFO of Pfizer Ltd. Life sciences companies setting an R&D portfolio, securing supply or planning a launch can match the question to the function.
Professionals to explore
Albert Bourla
LinkedInExperience: Chief Executive Officer · Pfizer
Albert Bourla has been Chief Executive Officer of Pfizer since 2019 and Chairman of the Board since 2020, after Chief Operating Officer (2018). Group President, Pfizer Innovative Health (2014-2017) and President & General Manager, Established Products (2010-2014) are among Albert's Pfizer roles; a veterinarian by training, Albert joined the company in 1993, which suits questions on company-wide strategy.
Is this you? Claim your profile and get paid for calls.
Amit Agarwal
LinkedInExperience: Executive Director Finance & Chief Financial Officer, Pfizer Ltd · Pfizer
Amit Agarwal has been Executive Director Finance & Chief Financial Officer, Pfizer Ltd since 2024, a C-level finance role, and is based in Mumbai. Unilever titles including General Manager Finance - Sales & Customer Development (2022-2024), General Manager - Internal Audit (2020-2022) and Finance Controller - Global Business Services (2016-2020) suit questions on finance, internal audit and controls.
Is this you? Claim your profile and get paid for calls.
Angela Lukin
LinkedInExperience: Global Primary Care & US President · Pfizer
Global Primary Care & US President at Pfizer since 2022, Angela Lukin is responsible for global brand strategy and the U.S. P&L for the Vaccines and Internal Medicines therapy areas, and sits on the Pfizer Global Biopharmaceuticals Business Leadership Team. Global President Hospital Business (2020-2022) and Regional President Oncology North America (2019-2020) add hospital and oncology commercial roles.
Is this you? Claim your profile and get paid for calls.
Chris Boshoff, MD, PhD, FMedSci
LinkedInExperience: Chief Scientific Officer and President, Research & Development · Pfizer
Chief Scientific Officer and President, Research & Development at Pfizer since 2025, Chris Boshoff leads the company's R&D strategy and execution in all therapeutic areas, including Inflammation & Immunology, Internal Medicines, Oncology and Vaccines. Chief Oncology Officer and Executive Vice President (since 2023) and Chief Development Officer, Pfizer Oncology (2018-2022) add oncology development.
Is this you? Claim your profile and get paid for calls.
Dennis Hancock
LinkedInExperience: Chief Information Officer, Executive Vice President · Pfizer
As Chief Information Officer, Executive Vice President at Pfizer since 2026, Dennis Hancock leads the company's enterprise digital, AI and technology strategy, with more than 30 years across Pfizer roles including R&D and global commercial solutions. Senior Vice President titles in digital health, AI and enterprise products (2021-2026) fit questions on digital and AI in pharma.
Is this you? Claim your profile and get paid for calls.
Jeremy Forman
LinkedInExperience: Former Chief AI, Data, & Analytics Officer · Pfizer
In 2026 Jeremy Forman became Chief AI, Data, & Analytics Officer at Pfizer, a C-level role, after Vice President, Global R&D AI, Data, & Analytics there (2024-2026). Executive Director AI & Data Strategy, Science, & Platforms at Seagen (2021-2024) and Director, Enterprise Architecture, Global Data & Analytics at Gates Foundation (2016-2021) suit questions on AI and data in R&D.
Is this you? Claim your profile and get paid for calls.
Mike McDermott
LinkedInExperience: Chief Global Supply Officer, Executive Vice President · Pfizer
Pfizer's internal and external manufacturing and supply chain activities are what Mike McDermott leads as Chief Global Supply Officer, Executive Vice President since 2022, working to ensure uninterrupted supply for the entire product portfolio. President, Pfizer Global Supply (2019-2022) and Vice President, Global Supply Chain (2014-2018) make Mike the person for supply continuity questions.
Is this you? Claim your profile and get paid for calls.
Nick Lagunowich
LinkedInExperience: Global President, Emerging Markets · Pfizer
Nick Lagunowich has been Global President, Emerging Markets at Pfizer since 2022, and was Global President, Internal Medicine (2020-2022), Regional President, Rare Disease (2020) and Regional President, Internal Medicine (2017-2020). Nick also held a Vice President and US Adult Lead, Pfizer Vaccines title and fits questions on commercial strategy across emerging markets.
Is this you? Claim your profile and get paid for calls.
Payal Sahni
LinkedInExperience: Chief People Experience Officer, Executive Vice President · Pfizer
Colleague experience, including culture, talent development, engagement, benefits, compensation and workplace experience, is Payal Sahni's responsibility as Chief People Experience Officer, Executive Vice President at Pfizer since 2022. Chief Human Resources Officer (2020-2022) and Senior Vice President Human Resources (1997-2020) at Pfizer suit questions on HR and colleague experience at a pharmaceutical company.
Is this you? Claim your profile and get paid for calls.
Tanya Alcorn
LinkedInExperience: Former President, Global Hospital & Biosimilars · Pfizer
Since 2025 Tanya Alcorn has been President, Global Hospital & Biosimilars at Pfizer, after Senior Vice President Operations (2022-2025), and was Vice President, BioPharma Global Supply Chain (2018-2022) and Sr. Director, Rare Disease Supply Chain Leader (2014-2016). An HBA board member, Tanya brings a supply chain background to hospital and biosimilars commercial questions.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For portfolio and pipeline questions, Chris Boshoff covers R&D across therapeutic areas and Albert Bourla covers the whole company. Mike McDermott and Tanya Alcorn fit manufacturing and supply chain, Angela Lukin and Nick Lagunowich fit commercial strategy by therapy area and region, Dennis Hancock and Jeremy Forman fit technology, AI and data, Payal Sahni fits people questions, and Amit Agarwal fits finance questions for Pfizer Ltd.
Questions to take into the conversation
- 01How does Pfizer's R&D leadership decide which therapeutic areas such as oncology, vaccines or internal medicine get more investment?
- 02What does it take to keep supply uninterrupted when a product portfolio mixes internal and external manufacturing?
- 03How does a Pfizer commercial president balance global brand strategy with the P&L for one market such as the US?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.